Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Skin oxygen tension is improved by immersion in oxygen-enriched water.

Autor: Reading, S. A.¹, Yeomans, M.¹, Levesque, C.¹

Publikováno v: International Journal of Cosmetic Science. Dec2013, Vol. 35 Issue 6, p600-607. 8p.

Increased cAMP as a positive inotropic factor for mammalian skeletal muscle in vitro.

Autor: Reading, S A, Murrant, C L, Barclay, J K

Publikováno v: Canadian Journal of Physiology & Pharmacology. Oct2003, Vol. 81 Issue 10, p986-996. 11p.

A[sub 1] receptor activation decreases fatigue in mammalian slow-twitch skeletal muscle in vitro.

Autor: Reading, S. A., Barclay, J. K.

Publikováno v: Canadian Journal of Physiology & Pharmacology. Jun2001, Vol. 79 Issue 6, p496-501. 6p.

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

Autor: Jovanovic, J.V., Ivey, A., Vannucchi, A.M., Lippert, E., Leibundgut, E. Oppliger, Cassinat, B., Pallisgaard, N., Maroc, N., Hermouet, S., Nickless, G., Guglielmelli, P., Reijden, B.A. van der, Jansen, J.H., Alpermann, T., Schnittger, S., Bench, A., Tobal, K., Wilkins, B., Cuthill, K., McLornan, D., Yeoman, K., Akiki, S., Bryon, J., Jeffries, S., Jones, A., Percy, M.J., Schwemmers, S., Gruender, A., Kelley, T.W., Reading, S., Pancrazzi, A., McMullin, M.F., Pahl, H.L., Cross, N.C., Harrison, C.N., Prchal, J.T., Chomienne, C., Kiladjian, J.J., Barbui, T., Grimwade, D.

Publikováno v: Jovanovic, J V; Ivey, A; Vannucchi, A M; Lippert, E; Oppliger Leibundgut, Elisabeth; Cassinat, B; Pallisgaard, N; Maroc, N; Hermouet, S; Nickless, G; Guglielmelli, P; van der Reijden, B A; Jansen, J H; Alpermann, T; Schnittger, S; Bench, A; Tobal, K; Wilkins, B; Cuthill, K; McLornan, D; ... (2013). Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia, 27(10), pp. 2032-2039. Nature Publishing Group 10.1038/leu.2013.219
Leukemia
Leukemia, 27, 2032-9
Leukemia, 27, 10, pp. 2032-9

Item does not contain fulltext Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor disease response. However, there has

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8db0b9a0e0a05667e1f59be8f8b90e3d
https://doi.org/10.1038/leu.2013.219